Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-25 @ 2:22 AM
NCT ID: NCT02556034
Eligibility Criteria: Inclusion Criteria: 1. Subject is ≥18 years of age. 2. Has at least one of the following diagnosis at screening * Subject has a diagnosis of RA as defined by the 1987- revised American College of Rheumatology (ACR)- classification criteria for RA and has disease duration of more than 6 months. * Subject must have a diagnosis of active PsA by Classification Criteria for Psoriatic Arthritis (CASPAR) and has disease duration of more than 6 months. 3. The subject must be able to provide written informed consent and to complete the study questionnaires. Exclusion Criteria: * Subject with DIP involvement in PsA * Subject with predominant axial symptoms (spondyloarthropathy) * Subject with fibromyalgia * Subject involved in a concomitant study * Subject currently takes ≥10 mg cortisone daily * Subject has taken opioid analgesics within 12 hours of joint count assessment
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT02556034
Study Brief:
Protocol Section: NCT02556034